Clinical Trials Logo

Burns clinical trials

View clinical trials related to Burns.

Filter by:

NCT ID: NCT00285636 Completed - Burn Clinical Trials

Long Term Follow-Up of Burn Injuries

Start date: June 1992
Phase: N/A
Study type: Observational

The purpose of the study is to investigate the psychological effects of burn injuries as experienced by patients.

NCT ID: NCT00285090 Terminated - Malnutrition Clinical Trials

Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury

Start date: February 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is two-fold. The first is to establish that bone mineral density is diminished among children admitted to this regional burn center as compared to healthy non-burned children. The second purpose of this study is to examine the short and long-term effects of calcium and vitamin D supplementation in on bone metabolism and accrual in children who have been burned. Specific Aims: 1) To measure bone mineral content and bone mineral density and their change during growth in convalescent burned children admitted to a regional burn center and to compare them to normal, healthy children.; 2) To measure lean body mass, fat mass, total body water in convalescent burned children admitted to a regional burn center and compare them to normal, healthy children with focus on how these components of body composition relate to indices of bone mineral content and density; 3) To identify alterations in bone metabolism and calcium and vitamin D homeostasis following burn injury and relate these to bone mineral density in burned children; 4) To test the effect of short term calcium and vitamin D supplementation on improving bone mineral density, bone mineral content, and indices of calcium and vitamin D metabolism in acutely burned children.

NCT ID: NCT00283426 Terminated - Burns Clinical Trials

Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns

Start date: January 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether soluble beta-1,3/1,6-glucan is an effective and safe treatment of thermal burns and non-injured skin where skin grafts are harvested. Hypothesis: Soluble beta-1,3/1,6-glucan will through its immunomodulating activities improve wound healing of thermal burns and non-injured skin where skin grafts are harvested.

NCT ID: NCT00261690 Completed - Burn Clinical Trials

Virtual Reality Pain Control During Burn Wound Care

VRPT/H2O/RT
Start date: February 2002
Phase: Phase 2/Phase 3
Study type: Interventional

Using Virtual Reality as a form of Distraction during Burn Care.

NCT ID: NCT00257244 Completed - Trauma Clinical Trials

Inflammation and the Host Response to Injury (Burns)

Start date: April 2004
Phase:
Study type: Observational

The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the human innate immune system, with particular emphasis on the inflammatory component of that system. No single research center or small group of centers has the capacity to delineate the integrated response of this complex biological system, which involves multiple molecular and genetic interactions that vary in time. Our proposal promotes the identification of important dynamic relationships that regulate the integration of this complex biological system, with the expectation that this understanding will ultimately impact the diagnosis, prognosis, and treatment of the hospitalized, severely injured patient.

NCT ID: NCT00257231 Completed - Trauma Clinical Trials

Inflammation and the Host Response to Injury (Trauma)

Start date: November 2003
Phase:
Study type: Observational

The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the human innate immune system, with particular emphasis on the inflammatory component of that system. No single research center or small group of centers has the capacity to delineate the integrated response of this complex biological system, which involves multiple molecular and genetic interactions that vary in time. Our proposal promotes the identification of important dynamic relationships that regulate the integration of this complex biological system, with the expectation that this understanding will ultimately impact the diagnosis, prognosis, and treatment of the hospitalized, severely injured patient.

NCT ID: NCT00255996 Completed - Burns Clinical Trials

Evaluation Of Linezolid Pk Profile In Burns Patients

Start date: May 2006
Phase: Phase 1
Study type: Interventional

Evaluation of linezolid pk profile in burns patients

NCT ID: NCT00253292 Terminated - Trauma Clinical Trials

Psychometric Study of Outcomes Instruments

Start date: January 1997
Phase: N/A
Study type: Observational

The purpose of this study is to develop a standardized, practical self-administered questionnaire to monitor young adult burn patients and to evaluate the effectiveness of burn management treatments with regard to improved function, physical appearance and other relevant outcomes.

NCT ID: NCT00253279 Not yet recruiting - Burn Clinical Trials

Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans

Start date: November 2009
Phase: Phase 1
Study type: Observational

Our specific aim is to gain an understanding of protein synthesis rates in burn patients at various times during their injury and recovery by using PET scans. This will be compared with healthy volunteer controls. We hope this will help optimize nutrition and care regimens for future burn patients.

NCT ID: NCT00243243 Completed - Burns Clinical Trials

Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of the study is to see if a medication (Recombinant Coagulation Factor VIIa or NovoSeven), normally used to stop bleeding in persons with a bleeding disorder, will lower the amount of blood lost during burn surgery.